|
| related topics |
| {control, financial, internal} |
| {stock, price, share} |
| {interest, director, officer} |
| {customer, product, revenue} |
| {loss, insurance, financial} |
| {cost, regulation, environmental} |
| {property, intellectual, protect} |
| {product, candidate, development} |
| {acquisition, growth, future} |
| {debt, indebtedness, cash} |
| {stock, price, operating} |
|
|
PAYMENT OF CERTAIN OUTSTANDING NOTES.
STATEMENT TO BE DECLARED EFFECTIVE.
AVAILABLE, WE MAY HAVE TO CURTAIL OR CEASE OPERATIONS.
WE HAVE NOT BEEN PROFITABLE AND EXPECT FUTURE LOSSES.
SUBSTANTIAL DOUBT ABOUT OUR ABILITY TO CONTINUE AS A GOING CONCERN.
DIFFICULT TO EVALUATE OUR FUTURE PROSPECTS.
HAVE A MATERIAL ADVERSE EFFECT ON OUR OPERATIONS AND FINANCIAL RESULTS.
THE SUPPLY OF WHICH IS REGULATED.
WE ARE DEPENDENT ON A SMALL NUMBER OF SUPPLIERS FOR OUR RAW MATERIALS AND ANY DELAY OR UNAVAILABILITY OF RAW MATERIALS CAN MATERIALLY ADVERSELY AFFECT OUR ABILITY TO PRODUCE PRODUCTS.
COMMERCIALIZATION OF DRUG PRODUCTS.
INSURANCE TO PROTECT IT AGAINST LOSSES.
CONTINUING INNOVATION TO PROTECT OUR PROPRIETARY INTERESTS.
PRICE FOR WHICH IT CAN BE SOLD.
ON THE TRADING PRICES OF OUR COMMON STOCK AS WELL AS A DILUTIVE EFFECT.
PRESENTATION OF MATTERS AT STOCKHOLDER MEETINGS.
Full 10-K form ▸
|
|
| related documents |
| 857953--4/2/2007--JMAR_TECHNOLOGIES_INC |
| 1057327--3/31/2009--COMCAM_INC |
| 1042173--3/14/2006--SCIENTIFIC_LEARNING_CORP |
| 1136711--12/23/2010--VOIS_Inc. |
| 1076505--4/15/2009--PLANKTOS_CORP |
| 843006--3/20/2009--ISSUER_DIRECT_CORP |
| 948545--3/16/2006--TALK_AMERICA_HOLDINGS_INC |
| 843006--4/1/2008--ISSUER_DIRECT_CORP |
| 1373444--11/29/2010--SOPAC_CELLULAR_SOLUTIONS_INC. |
| 1425883--5/26/2010--Independent_Film_Development_CORP |
| 1365022--6/30/2008--Coronado_Corp. |
| 1365022--7/7/2009--Coronado_Corp. |
| 84581--3/31/2008--ROCK_OF_AGES_CORP |
| 1024452--9/28/2007--SMF_ENERGY_CORP |
| 1423586--2/26/2010--Quadra_Projects_Inc. |
| 22872--8/18/2006--COMPREHENSIVE_CARE_CORP |
| 12570--4/28/2009--LEXINGTON_PRECISION_CORP |
| 834365--3/31/2009--BIOLIFE_SOLUTIONS_INC |
| 774517--6/25/2009--AMERICAN_CLAIMS_EVALUATION_INC |
| 891288--3/18/2008--QUESTCOR_PHARMACEUTICALS_INC |
| 1031233--3/27/2008--PINNACLE_BANKSHARES_CORP |
| 1342287--2/23/2007--General_Finance_CORP |
| 1380856--11/12/2008--APRECIA_INC |
| 753772--3/15/2010--MEDIZONE_INTERNATIONAL_INC |
| 1301843--10/21/2009--Quantum_Ventures_Inc. |
| 1104672--4/13/2010--MONTANA_MINING_CORP |
| 311094--2/28/2008--WESTAMERICA_BANCORPORATION |
| 1366823--3/27/2009--SPRING_CREEK_CAPITAL_CORP. |
| 311094--3/10/2006--WESTAMERICA_BANCORPORATION |
| 874015--3/16/2007--ISIS_PHARMACEUTICALS_INC |
|